It was demonstrated that synergistic use of OV-IL15C plus epidermal growth factor (EGFR)-CAR NK cells was able to suppress glioblastoma (GBM) cells and also enhanced the infiltration of NK and CD8+ T cells [106]. The gene discussed is EGFR; the disease is glioblastoma.